Expression of Molecular Markers Before and After Neo-adjuvant Chemoradiotherapy in Rectal Cancer

NCT00835055CI-TRIAL-00037961withdrawnClinicalTrials.gov clinicaltrialsPublishedExplore in graph →

Why stopped (as posted): never started several reasons

Summary

Brief summary (as posted)

The purpose of this study is to determine whether markers on tumor tissue may be an indicator for good response to neoadjuvant chemoradiotherapy in patients with rectal cancer.

Conditions

Conditions (1)

Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.

Condition (as posted)	Mapped entity	Match	Confidence
Rectal Cancer	Malignant Rectal Neoplasm	CURATED_EXACT	0.92

Interventions

Interventions (0)

Data not yet available

No intervention recorded.

Eligibility

Eligibility (as posted)

Sex: All

Show eligibility criteria text

Inclusion Criteria:

* locally advanced rectal cancer uT3 or uT4
* no distant metastasis
* neoadjuvant radiochemotherapy required

Exclusion Criteria:

* rejection of radiochemotherapy

References

Publications (0)

Data not yet available

No reference posted for this study.

Registry

Dates and enrollment

Start: Apr 1, 2005
Primary completion: Apr 1, 2019
Completion: Apr 1, 2019
First posted: Feb 3, 2009
Last update posted: Apr 5, 2019
Enrollment: 0 (actual)
Lead sponsor: St. Claraspital AG OTHER
Keywords: rectal cancer with neoadjuvant treatment, standardized clinical tests, tumor markers on tumor tissue

Data updated 22 days agoSource updated Apr 5, 2019source: clinicaltrials

Locations

Locations by country (1)

Country	Sites	Recruiting
Switzerland	1	0

Trial listing is informational. Eligibility is decided by the study team; contact information is on ClinicalTrials.gov.